Investment Type: Grant
Organization Type: Nonprofit
Cambridge Reproductive Health Consultants (CRHC) improves reproductive health and fosters reproductive justice by leveraging the skills of professionals from a variety of fields and disciplines. CRHC focuses on increasing access to safe, legal, high quality, and affordable abortion care, reducing harm from unsafe abortion, increasing access to emergency contraception and long-acting reversible contraceptive methods, and advancing new reproductive health technologies.
Why we invest:
We provided a restricted grant to CRHC to conduct a scoping review of the efficacy of current medication abortion regimens (mifepristone/misoprostol and misoprostol alone) during the timeframe of 28-35 days from the last menstrual period in order to expand knowledge of the potential for very early use of medication abortion drugs to ensure a state of non-pregnancy or induce very early pregnancy loss.